Intestinal candidiasis: what the tests cannot tell you
In brief
This subject is a trap on both sides. On one hand, the glass of water test and the kits sold online measure nothing: Candida lives in the gut of most healthy people, so finding it proves nothing. On the other, waving the question away would be wrong: intestinal fungal overgrowth has become a research topic in its own right, linked to persistent digestive symptoms, particularly in people who do not respond to treatments aimed at bacteria. The real problem lies elsewhere: to date there is no standardised diagnostic criterion and no validated non-invasive tool.
Search for “intestinal candidiasis” and you will land in two worlds that do not speak to each other. On one side, sites that have you spit into a glass of water on waking and sell three-month courses. On the other, near-total silence from medicine, which files the subject among the inventions of marketing.
Both positions suit everyone except the person with stomach pain. This article takes the subject differently: what Candida actually does in a gut, what the tests on offer are worth, what recent research recognises, and above all where to turn when the symptoms are genuinely there. It is for information and does not replace your doctor’s assessment.
Candida: a normal resident of the gut
A yeast present in most people
Candida albicans is a commensal yeast: it is part of the normal flora of the digestive tract, the mouth and other mucous membranes in a large share of the healthy population. Its presence is therefore not an abnormality. This is the point where most of the reasoning read online collapses: finding Candida proves nothing, since it is also found in people who are perfectly well.
What is found in ordinary people
A community study in Malaysia cultured stool samples from participants in a general population: culturable fungi were present in 45 % of them[4]. Its authors highlight above all a point that is crucial for our subject: to date there is no established reference describing what a normal gut mycobiome would be. Without a norm, there is no way to say a result is “too high”.
What the mycobiome is
Alongside bacteria, the gut hosts fungi, viruses and other micro-organisms. This fungal community has a name, the mycobiome, and it long remained in research’s blind spot, which focused on bacteria. Recent sequencing techniques have changed that and brought its role in gut balance to light[1].
The real candidiasis medicine knows about
There are well-characterised Candida infections: oral candidiasis, oesophageal candidiasis, invasive forms. They occur mainly in people whose defences are weakened, on chemotherapy, on immunosuppressants or in intensive care. They are diagnosed and treated, and they have nothing to do with the chronic fatigue attributed online to “candidiasis”.
What the glass of water test cannot tell you
The supposed principle
The procedure circulates everywhere: spit into a glass of water on an empty stomach and watch for twenty minutes. Strands sinking down are said to signal an overgrowth. This reading has no basis: what you see in a glass depends on the viscosity of saliva, on hydration, on mouth cells and on plain gravity, not on the quantity of yeast in the colon.
The underlying problem
It is not just about that one test. A 2026 review devoted to intestinal fungal overgrowth puts it bluntly: diagnosis remains difficult for want of standardised criteria and validated non-invasive tools[2]. In other words, no consumer test can establish this diagnosis today, because medicine itself does not yet have one.
The kits sold online
The same reasoning applies to stool analyses sold direct to consumers and to antibody tests supposed to reveal an “overload”. They often report the presence of Candida, which is expected in a healthy person, and then offer the matching course of treatment. A positive result is not proof when the target is present in almost everyone.
What research recognises, and which deserves saying
Fungal overgrowth does exist
This is the nuance the sceptical camp forgets. Recent literature describes an entity, intestinal fungal overgrowth, associated with persistent digestive symptoms: bloating, abdominal discomfort, altered bowel habit. It is considered above all in patients who do not respond to treatments targeting bacterial overgrowth[2].
Through which mechanisms
The pathways described are concrete: activation of the immune system, disruption of the gut barrier, biofilm formation, and production of toxic metabolites such as acetaldehyde or candidalysin[2]. These are plausible, documented mechanisms, not “toxin” metaphors of the kind found on sites selling courses.
The link with irritable bowel
A review devoted to the non-bacterial microbiota notes that people with irritable bowel syndrome show lower fungal and viral diversity, along with changes in the mycobiome[1]. Fungi there are associated with distinct symptoms and could contribute to visceral hypersensitivity. The direction of the relationship remains undetermined: it is unknown whether the imbalance is cause or consequence.
Antibiotics: the lasting effect nobody talks about
A revealing experiment
Fourteen healthy people received six days of antibiotics, then were followed for three months with joint analysis of bacteria and fungi. The bacteria largely recovered. The mycobiome, however, shifted from a cooperative to a competitive mode, and half the interactions initially observed between bacteria and fungi had disappeared three months later[3].
Why this is interesting
This study also identified bacteria capable of holding back Candida albicans, and showed in the laboratory that bacterial metabolites such as propionate limited its pathogenic power[3]. That gives a serious framework to a widespread intuition: after a course of antibiotics, the balance between bacteria and yeasts takes time to rebuild. It is not “candidiasis”, it is a disturbed ecology.
What we are really looking for behind these symptoms
The hypotheses to rule out first
Bloating, a stomach that swells by the end of the day, unstable bowel habit, tiredness after meals: these symptoms are real and deserve a proper approach, not a label. The avenues that are genuinely documented are irritable bowel syndrome, small intestinal bacterial overgrowth, a food intolerance, coeliac disease, or an effect of current medication.
The useful approach
It starts with a doctor, not with an online test. A clinical examination, a few targeted tests and sometimes a breath test make it possible to rule out or confirm these avenues. A food and symptom diary kept for two to three weeks often yields more information than a hundred-franc kit, because it links symptoms to concrete situations.
| Item | Status |
|---|---|
| Candida present in the gut | Normal in a large share of the population |
| Saliva-in-a-glass test | No biological basis |
| Consumer stool or antibody kits | No standardised diagnostic criterion to date |
| Intestinal fungal overgrowth | Recognised research entity, with no validated tool |
| Oral, oesophageal, invasive candidiasis | Established medical diagnoses |
Are anti-candida courses worth anything?
The no-sugar, no-yeast diet
The so-called anti-candida diet removes sugars, yeasts, matured cheeses and sometimes fruit, for weeks. Many people feel better on it, and that is explainable without invoking yeasts: these diets also remove a large part of ultra-processed foods and alcohol. No solid data show that they reduce a fungal population in the gut.
“Natural” antifungals
Grapefruit seed extract, caprylic acid, oregano essential oils: these products are sold as gentle antifungals. They are neither harmless nor free of interactions, and their effectiveness on the human gut mycobiome is not established. Antifungal treatments with demonstrated efficacy are medicines, reserved for diagnosed situations.
What remains sensible
A diet rich in plants and fibre, limited alcohol, enough sleep, and medical follow-up of symptoms that last. It is not spectacular, but it holds up. Ongoing research on the mycobiome may open other avenues; they do not yet exist in the form of a course to buy.
The subject deserves better than the duel between sellers of courses and a shrug of the shoulders. Candida is a normal resident of the gut, no consumer test allows an overgrowth to be asserted, and yet research describes a fungal entity linked to very real symptoms, without yet knowing how to measure it.
If your symptoms brought you here, two avenues are far better documented and deserve exploring first: SIBO, the small intestinal bacterial overgrowth that explains a great deal of persistent bloating, and the role of the gut flora in day-to-day digestive comfort.
Frequently asked questions
Is the saliva-in-a-glass test reliable?
No, it measures nothing. What you see in the glass depends on the viscosity of your saliva, on hydration and on mouth cells, not on the quantity of yeast in your colon. More broadly, a recent review stresses that diagnosing intestinal fungal overgrowth remains difficult for want of standardised criteria and validated non-invasive tools. No consumer test can therefore establish this diagnosis today.
Does intestinal candidiasis really exist?
It depends what you mean. Oral, oesophageal and invasive candidiasis are established medical diagnoses, above all in immunocompromised people. The chronic candidiasis syndrome sold online, supposed to explain fatigue and brain fog, is not a recognised entity. Between the two, research describes intestinal fungal overgrowth associated with persistent digestive symptoms, which it does not yet know how to measure reliably.
Which symptoms are wrongly blamed on Candida?
Chronic fatigue, brain fog, sugar cravings, diffuse aches: these appear on online questionnaires, but nothing allows them to be tied to an intestinal yeast. Digestive symptoms, on the other hand, are real and deserve a proper approach: bloating, unstable bowel habit, discomfort after meals. They point first to irritable bowel syndrome, SIBO, a food intolerance or coeliac disease.
Does the anti-candida diet work?
Some people feel better on it, but probably not for the reason given. These diets remove sugars and yeasts, and with them a good part of ultra-processed products and alcohol. No solid data show that they reduce a fungal population in the gut. A prolonged restrictive diet is also not harmless nutritionally: better to discuss it with a professional.
Do antibiotics favour yeasts?
They unbalance the relationship between bacteria and fungi for a long time. In a study following fourteen healthy adults for three months after six days of antibiotics, the bacteria largely recovered, but the mycobiome shifted from cooperation to competition, and half the initial interactions had disappeared at three months. The authors also identified bacteria capable of holding back Candida albicans.
Should you take natural antifungals?
They are neither harmless nor demonstrated. Grapefruit seed extract, caprylic acid or oregano essential oils carry possible interactions with medicines, and their effect on the human gut mycobiome is not established. Antifungals with proven efficacy are prescription medicines, reserved for situations diagnosed by a doctor.
Can a probiotic help?
Not as a treatment: a food supplement does not treat, prevent or cure an infection. What research shows is that certain gut bacteria limit the pathogenic power of Candida albicans in the laboratory, which explains the interest in the balance of the flora. For many people the concrete goal remains simpler: regaining regular digestive comfort, particularly after a course of antibiotics.
Who should you see, and when?
Your family doctor first, as soon as digestive symptoms last more than a few weeks, and without delay in case of weight loss, blood in the stool, fever or night pain. They can rule out the common causes and, if needed, refer you to a gastroenterologist. Arriving with a food and symptom diary covering two to three weeks makes the consultation considerably more useful.
Sources and references (verified on PubMed)
4 sources- Liu A., Gao W., Zhu Y., Hou X., Chu H. (2022). Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome.
- Im J., Lee K., Lee S.-H., Jung S., Kim K.-N., Lee J. (2026). Clinical Significance of Intestinal Fungal Overgrowth: Integrating the Gut Mycobiome into Modern Gastroenterology.
- Seelbinder B. et al. (2020). Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria.
- Huët M.A.L. et al. (2021). Investigation of culturable human gut mycobiota from the Segamat community in Johor, Malaysia.